Study guide
21.2 Cutaneous Reconstructive Flaps, Skin Grafts & Surgical Complications
UEMS European Board of Dermatovenereology Diploma Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Eligibility & Examination Regulations
1.1 EBDVD Exam Format, Session Timing & Scoring Rules 1.2 Eligibility Routes, Application Requirements & Re-take Regulations 1.3 UEMS-EBDV Governance, European Training Requirements & Diploma Recognition
2 Chapter 2: Dermatologic Terminology, Lesion Morphology & Skin Biology
2.1 Skin Anatomy, Epidermal Biology & Barrier Function 2.2 Primary & Secondary Lesion Morphology 2.3 Cutaneous Immunology & Pathophysiological Reaction Patterns
3 Chapter 3: Dermatopathology & Diagnostic Procedures
3.1 Biopsy Selection, Processing & Special Staining Techniques 3.2 Major Histopathologic Patterns & Tissue Reaction Types 3.3 Direct & Indirect Immunofluorescence Microscopy
4 Chapter 4: Epidemiology, Photobiology & Occupational Dermatology
4.1 Epidemiological Principles & Cutaneous Disease Burden 4.2 Photobiology & Photoprotection 4.3 Occupational Dermatoses & Contact Sensitisation Surveillance
5 Chapter 5: Papulosquamous, Follicular & Adnexal Disease
5.1 Psoriasis: Variants, Psoriatic Arthritis, Comorbidity & European Management 5.2 Lichen Planus, Lichenoid Eruptions & Other Papulosquamous Disorders 5.3 Acne Vulgaris, Rosacea & Perioral Dermatitis 5.4 Hidradenitis Suppurativa, Hyperhidrosis & Other Sweat Gland Disorders
6 Chapter 6: Hair, Nails & Pigmentary Disorders
6.1 Hair Disorders: Non-Scarring & Scarring Alopecia, Hair Shaft Defects & Hirsutism 6.2 Nail Disorders, Onychomycosis & Nail Unit Tumours 6.3 Pigmentary Disorders: Vitiligo, Melasma & Other Hypo- and Hyperpigmentation
7 Chapter 7: Drug Reactions, Granulomatous & Deposition Disease and Skin Signs of Systemic Disease
7.1 Cutaneous Adverse Drug Reactions, SCARs & Dermatological Emergencies 7.2 Granulomatous & Deposition Disorders and Panniculitis 7.3 Skin Signs of Systemic Disease, Porphyrias, Nutritional Deficiency & Paraneoplastic Dermatoses
8 Chapter 8: Pruritus, Pregnancy & Geriatric Dermatology, Physical Injury and Mucosal Disease
8.1 Chronic Pruritus, Chronic Prurigo, Dermatoses of Pregnancy & Geriatric Dermatology 8.2 Burns, Cold, Heat & Radiation Injury and the Principles of Wound Healing 8.3 Oral Mucosal, Lip, Genital Mucosal & Perianal (Proctological) Disease
9 Chapter 9: Autoimmune Bullous Diseases
9.1 Pemphigus Group: Pemphigus Vulgaris, Foliaceus & Paraneoplastic Pemphigus 9.2 Pemphigoid Group & Epidermolysis Bullosa Acquisita 9.3 Dermatitis Herpetiformis & Linear IgA Bullous Dermatosis
10 Chapter 10: Eczematous Disorders, Urticaria & Allergology
10.1 Atopic Dermatitis: Pathogenesis, Phenotypes & European Management 10.2 Allergic & Irritant Contact Dermatitis: Pathogenesis, Investigation & Common Allergens 10.3 Urticaria, Angioedema & Cutaneous Mastocytosis 10.4 Immediate-Type Allergy: Diagnostics, Anaphylaxis, Food, Venom & Drug Allergy
11 Chapter 11: Connective Tissue Diseases & Cutaneous Vasculitis
11.1 Cutaneous Lupus Erythematosus Spectrum & Systemic Manifestations 11.2 Dermatomyositis, Systemic Sclerosis & Scleroderma Spectrum 11.3 Cutaneous Vasculitis & Neutrophilic Dermatoses
12 Chapter 12: Paediatric & Genetic Dermatology
12.1 Vascular Anomalies & Benign Neonatal Dermatoses 12.2 Hereditary Ichthyoses & Disorders of Keratinisation 12.3 Genodermatoses, Neurocutaneous Syndromes & Epidermolysis Bullosa
13 Chapter 13: Bacterial, Mycobacterial, Parasitic & Zoonotic Cutaneous Infections
13.1 Bacterial Skin & Soft Tissue Infections 13.2 Mycobacterial Infections: Cutaneous Tuberculosis, Leprosy & Atypical Mycobacteria 13.3 Parasitic Infestations, Arthropod Bites & Cutaneous Leishmaniasis 13.4 Lyme Borreliosis, Rickettsioses & Other Zoonotic and Travel-Related Skin Infections
14 Chapter 14: Viral & Fungal Cutaneous Infections
14.1 Herpesviridae Infections: HSV, VZV & HHV-8 14.2 Poxviruses & Human Papillomavirus Manifestations 14.3 Superficial, Subcutaneous & Deep Mycoses
15 Chapter 15: Sexually Transmitted Infections & Genital Infections
15.1 Syphilis: Pathogenesis, Clinical Stages, Serology & European Management 15.2 Neisseria gonorrhoeae, Chlamydia trachomatis & Genital Ulcer Diseases 15.3 HIV-Related Dermatoses, Partner Notification & Anogenital Lichen Sclerosus 15.4 Non-Gonococcal Urethritis, Mycoplasma genitalium, Trichomoniasis, Vaginal Infections & Balanitis
16 Chapter 16: Sexual Health Services, HIV Prevention & Anogenital Medicine
16.1 STI Epidemiology, Prevention, Services, Sexual History, HIV Testing, ART & PrEP/PEP 16.2 HPV-Related Anogenital Neoplasia, Cervical Screening & Common Gynaecological and Andrological Disorders 16.3 STIs in Pregnancy, Neonates & Children, Contraception, Sexual Health & Psychosexual Problems
17 Chapter 17: Keratinocyte Carcinomas, Precancerous Lesions & Other Skin Tumours
17.1 Actinic Keratoses, Bowen Disease & Field Cancerisation 17.2 Basal Cell Carcinoma: Subtypes, Risk Stratification & Management 17.3 Cutaneous Squamous Cell Carcinoma & Keratoacanthoma 17.4 Benign & Malignant Epidermal, Adnexal, Mesenchymal and Vascular Tumours, Cysts, Histiocytoses & Metastases
18 Chapter 18: Melanocytic Naevi & Melanoma
18.1 Benign Melanocytic Naevi: Acquired, Congenital, Spitz, Blue, Halo & Atypical Naevi 18.2 Melanoma Risk Factors, Clinical Presentation & Biopsy Protocol 18.3 Melanoma Histopathology, Breslow Thickness & Staging 18.4 Systemic Therapy for Advanced & Metastatic Melanoma
19 Chapter 19: Dermoscopy, Skin Imaging & Cutaneous Lymphomas
19.1 Dermoscopic Principles, Structures & Algorithmic Approaches 19.2 Dermoscopy of Non-Melanocytic Cutaneous Neoplasms 19.3 Non-Invasive Skin Imaging, Skin Function Measurement, Teledermatology & Skin Cancer Surveillance 19.4 Cutaneous Lymphomas, Merkel Cell Carcinoma & Cutaneous Sarcomas
20 Chapter 20: Dermatopharmacology, Systemic Therapeutics & Prescribing
20.1 Topical Corticosteroids, Calcineurin Inhibitors & Retinoids 20.2 Systemic Immunosuppressive & Biologic Therapies 20.3 Oral Retinoids & Phototherapy Modalities 20.4 Dermatological Prescribing: Anti-Infectives, Antihistamines, Antimalarials, Dapsone, Special Populations & Cutaneous Toxicity of Cancer Therapy
21 Chapter 21: Dermatosurgery, Cryotherapy, Lasers & Aesthetic Procedures
21.1 Surgical Anatomy, Local Anaesthesia & Excision Principles 21.2 Cutaneous Reconstructive Flaps, Skin Grafts & Surgical Complications 21.3 Cryosurgery, Electrosurgery & Cutaneous Lasers 21.4 Aesthetic & Corrective Dermatology, Photodynamic Therapy & Dermatological Radiotherapy
22 Chapter 22: Phlebology, Angiology, Psychodermatology & EBDVD Revision
22.1 Phlebology, Chronic Venous Insufficiency & Lower Extremity Ulcers 22.2 Angiology: Arterial Disease, Raynaud Phenomenon, Livedo, Thrombosis, Lymphoedema & Lipoedema 22.3 Psychodermatology, Delusional Infestation & Factitious Disorders 22.4 EBDVD Revision Strategy & Cross-Topic Review
21.2 Cutaneous Reconstructive Flaps, Skin Grafts & Surgical Complications
Key Takeaways Explain This Topic AI
The reconstructive ladder dictates a logical progression of defect closure from simplest to most complex: secondary intention healing, direct primary linear closure, local skin flaps, full-thickness skin grafts (FTSG), split-thickness skin grafts (STSG), and distant/free tissue transfer.
Cutaneous flaps maintain an intrinsic vascular supply and are classified as random-pattern (perfused by the dermal/subdermal plexus with limited length-to-width ratios) or axial-pattern (perfused by a named anatomically defined cutaneous artery, such as the supratrochlear artery feeding the paramedian forehead flap).
Transposition flaps recruit adjacent mobile skin across an intervening bridge of normal tissue; classic paradigms include the Rhomboid (Limberg) flap (for 60°/120° rhombic defects aligned with lines of maximum extensibility) and the Zitelli bilobed flap (employing a 90° total rotational arc for lower third nasal reconstruction).
Skin graft survival progresses through three strict physiological stages: plasmatic imbibition (hours 0–48; passive nutrient absorption via host bed transudate), inosculation (days 2–4; microvascular alignment and direct anastomosis), and revascularization/neovascularization (day 4 onwards; host capillary ingrowth and lymphatic restoration).
Postoperative haematoma represents the single most common cause of both skin graft failure and flap necrosis; prevention requires meticulous intraoperative hemostasis, dead space obliteration, and immobilization with bolster (tie-over) dressings.
Last updated: September 2026
- 21.2 Cutaneous Reconstructive Flaps, Skin Grafts & Surgical Complications
- The Reconstructive Ladder & Defect Evaluation
When confronting a surgical defect following tumor extirpation, the reconstructive surgeon must systematically evaluate wound characteristics—including anatomical location, depth, exposure of bone or cartilage, quality of the recipient vascular bed, proximity to facial free margins, and patient comorbidities. The reconstructive ladder provides an established cognitive hierarchy, encouraging surgeons to choose the simplest, safest, and most aesthetically sound method before escalating to complex procedures. [ 6. Distant / Free Microvascular Transfer ]
- ▲
- │
- [ 5. Split-Thickness Skin Graft (STSG) ]
- ▲
- │
- [ 4. Full-Thickness Skin Graft (FTSG) ]
- ▲
- │
- [ 3. Local Cutaneous Tissue Flap ]
- ▲
- │
- [ 2. Primary Direct Linear Closure ]
- ▲
- │
- [ 1. Secondary Intention Healing ]
- The Rungs of the Reconstructive Ladder
Secondary Intention Healing:
Healing occurs spontaneously via granulation tissue formation, wound contraction (mediated by alpha-smooth muscle actin-rich myofibroblasts), and peripheral epithelial migration.
Ideal Indications: Concave anatomical facial regions where natural shadow and skin concavity hide scars and contraction causes minimal structural distortion. These include the medial canthus of the eye , concavity of the temple , alar crease / nasofacial sulcus , and the conchal bowl / scaphoid fossa of the auricle .
Absolute Contraindications: Convex surfaces (nasal tip, chin, malar cheek) where contraction results in depressed, atrophic, hypopigmented scars; and sites adjacent to facial free margins (lower eyelid, alar rim, vermilion border) where cicatricial contracture produces debilitating ectropion or nostril collapse.
Primary Direct Linear Closure:
The standard of care whenever surrounding tissue laxity permits closure without excessive wound tension or distortion of neighboring free margins.
Local Cutaneous Flaps:
Adjacent tissue transferred into the defect while retaining its own intrinsic vascular supply. Provides an exceptional match in color, texture, thickness, sebaceous pore density, and actinic damage.
Full-Thickness Skin Grafts (FTSG):
Composed of the entire epidermis and full dermis. Requires a healthy, well-vascularized wound bed (perichondrium, periosteum, or granulation tissue). Excellent aesthetic match with minimal secondary contracture.
Split-Thickness Skin Grafts (STSG):
Composed of the epidermis and a variable portion of the upper dermis. High take rate even on compromised beds, but undergoes marked secondary contraction and yields poor cosmetic blending.
Distant & Microvascular Free Flaps:
Reserved for massive composite defects, irradiated wound beds, or full-thickness multi-layer resections where local options are exhausted.
Cutaneous Flaps: Biomechanics & Classifications
A cutaneous flap consists of skin and subcutaneous tissue harvested from an adjacent or distant donor site that is mobilized into a surgical defect while maintaining an intact, functional microvascular perfusion pedicle.
- Vascular Classification: Random-Pattern vs. Axial-Pattern Flaps
- Random-Pattern Flaps
Microvascular Anatomy: Rely entirely on the un-named microvascular anastomotic networks of the dermal and subdermal plexuses. Perfusion pressure dissipates across the base of the flap.
Safe Dimensions: Because blood flow depends on passive intradermal perfusion pressure, the length-to-width ratio of a random flap must be strictly respected:
On the trunk and extremities: 1:1 to 1.5:1 (rarely 2:1).
On the face (due to immense microvascular density): 2:1 to 3:1 .
Most local advancement, rotation, and transposition flaps are random-pattern flaps.
Axial-Pattern Flaps
Microvascular Anatomy: Built around an anatomically named, direct cutaneous artery and its accompanying venae comitantes running longitudinally along the axis of the flap.
Safe Dimensions: Because perfusion is maintained by arterial pressure along the length of the vessel, axial flaps can be constructed with length-to-width ratios exceeding 4:1 to 6:1 with minimal risk of distal tip ischemia.
The Hallmark Axial Flap in Dermatosurgery: The Paramedian Forehead Flap .
Vascular Basis: Fed by the supratrochlear artery (an internal carotid branch originating from the ophthalmic artery, which emerges from the orbit 1.5 to 2.0 cm lateral to the facial midline).
Clinical Indications: The gold standard for reconstructing deep, complex, multi-layer, or subtotal defects of the nasal tip, columella, dorsum, and alar lobules.
Surgical Execution: Typically performed as a staged procedure: Stage 1 involves elevation and transposition of the forehead skin over an intact cutaneous vascular pedicle; Stage 2 (or intermediate stage at 2–3 weeks) involves thinning and sculpting; Final stage (at 3–4 weeks) involves pedicle division, transection, and inset of the proximal pedicle back into the medial eyebrow. RANDOM-PATTERN FLAP AXIAL-PATTERN FLAP
- ┌──────────────────────┐ ┌──────────────────────┐
- │ Dermal / Subdermal │ │ Named Direct │
- │ Microvascular │ │ Cutaneous Artery │
- │ Plexus Only │ │ (e.g., Supratrochlear)│
- └──────────────────────┘ └──────────────────────┘
- │ │
- ▼ ▼
Length-to-Width Ratio: Length-to-Width Ratio:
- 1:1 to 2:1 (Trunk/Limbs) 4:1 to 6:1+ (Robust Perfusion)
- 2:1 to 3:1 (Face) Staged Reconstruction (Forehead)
- Flap Movement Mechanics: Geometrical Configurations
- 1. Advancement Flaps
Advancement flaps move in a direct, linear vector into the defect without lateral rotation or transposition.
Single-Pedicle Advancement: A rectangular flap mobilized forward into an adjacent rectangular defect. Advancing the flap produces tissue bunching at its base, which must be excised as paired Burow's triangles along the base to allow flat movement.
Bilateral Advancement (H-Plasty / U-Plasty): Two opposing single-pedicle advancement flaps brought together to meet in the midline; ideal for forehead defects where scars follow horizontal forehead furrows.
V-Y Advancement Flap (Island Pedicle / Kite Flap):
A triangular island of skin is incised over or adjacent to a defect. The cutaneous margins are completely severed, but the flap remains tethered to a rich, mobile deep subcutaneous vascular pedicle .
The triangular island is advanced forward into the defect. The secondary defect left behind the advancing triangle is closed linearly in a straight line, converting the original 'V' incision into a completed 'Y'.
Prime Indications: Nasolabial fold, upper lip, medial cheek, and nasal sidewall.
2. Rotation Flaps
Rotation flaps swing along a semicircular arc around a central pivot point into an immediately adjacent triangular defect.
Geometrical Principles: The circumference of the rotation arc should be at least 4 to 5 times the width of the defect base . A short arc generates excessive radial tension, leading to flap ischemia.
Tension Relief: If the flap is under tension upon closure, a small back-cut can be incised at the pivot point toward the center of the circle, or a Burow's triangle can be excised along the outer perimeter.
Prime Indications: Scalp reconstruction (where the rigid galea precludes linear closure) and large medial/lateral cheek defects.
3. Transposition Flaps
Transposition flaps are mobilized across an intervening bridge of intact, normal skin to enter the surgical defect. This unique mechanical capability allows the surgeon to recruit skin from an area of high laxity and transpose it into an area of severe tissue deficiency. A. Rhomboid (Limberg) Flap
Geometrical Design: Designed for a rhombus-shaped defect with opposite interior angles of 60 degrees and 120 degrees .
Construction: The short diagonal of the rhombus (connecting the two 120° angles) is extended beyond the defect by a distance equal to the length of one side (L). A second line of length L is then incised parallel to one of the adjacent defect sides. For any given rhombic defect, four distinct Limberg flaps can be theoretically constructed.
Line of Maximum Tension: The primary defect is filled with zero tension; however, the secondary donor defect must be closed primarily under significant tension. Therefore, the closure of the secondary defect must be oriented strictly along the patient's Relaxed Skin Tension Lines (RSTLs) .
Webster Modification: Uses a 30-degree apical angle with an M-plasty at the base, minimizing closure tension in tight anatomical sites. B. Bilobed Flap (Esser / Zitelli Modification)
Anatomical Niche: The definitive local transposition flap for reconstructing defects on the lower third of the nose (nasal tip, supratip, and alar lobule) and the medial cheek.
The Zitelli Paradigm: In 1989, John Zitelli revolutionized the historical Esser bilobed flap (which used a 180-degree total rotational arc that caused severe flap bunching and pincushioning). Zitelli restricted the total rotational arc to 90 degrees :
The primary lobe (lobe 1) rotates approximately 45 degrees from the defect.
The secondary lobe (lobe 2) rotates an additional 45 degrees (90 degrees total from defect).
Sizing Metrics:
The primary lobe (lobe 1) is designed with an area equal to 100% of the primary defect .
The secondary lobe (lobe 2) is designed slightly smaller than lobe 1 and is recruited from the lax skin of the upper nasal dorsum and lateral sidewall.
The secondary donor defect left by lobe 2 is closed primarily in a linear fashion, and a small Burow's triangle is excised at the pivot point to prevent standing cone formation.
Summary Table: Cutaneous Flaps in Dermatological Surgery
Flap Category Specific Flap Type Geometric Design & Mechanics Primary Anatomical Indications Key Surgical Principles & Pitfalls
Advancement Single Pedicle Linear forward movement; paired Burow's triangles excised at base. Forehead, eyebrow, lower lip. Vector of motion is straight; minimal rotation; requires peripheral tissue laxity.
Advancement V-Y Island Pedicle Triangular island released from dermis; moved forward on deep subcutaneous pedicle. Upper lip, melolabial fold, nasal sidewall, cheek. Must preserve underlying subcutaneous vascular pedicle; close tail as 'Y'.
Rotation Classic Rotation Semicircular arc around pivot point; arc length 4–5× defect width. Scalp, medial/lateral cheek, temple. Back-cut or Burow's triangle relieves radial tension; wide undermining required.
Transposition Rhomboid (Limberg) Transposed into 60°/120° rhombic defect; short diagonal extended by side length L. Cheek, temple, chin, eyelids. Closure of secondary donor defect bears maximum tension; must align with RSTLs.
Transposition Bilobed (Zitelli) Dual-lobe transposition through a restricted total arc of 90° (45° per lobe). Nasal tip, supratip, alar lobule, medial cheek. Lobe 1 = defect size; Lobe 2 slightly smaller; recruits dorsal nasal skin; avoids alar distortion.
Axial Pattern Paramedian Forehead Longitudinal axial flap based on supratrochlear artery; staged pedicle division. Full-thickness nasal tip, columella, alae, dorsum. Gold standard nasal reconstruction; staged at 3–4 weeks; Doppler localization of artery.
Skin Grafts: Biology, Harvesting & Fixation
A skin graft consists of a segment of epidermis and dermis completely detached from its donor site and vascular supply, transferred to a recipient bed from which it must establish an entirely new microvascular network.
- Split-Thickness vs. Full-Thickness Skin Grafts EPIDERMIS ─────────────────────────┐
- │ STSG (Thin: 0.15–0.3 mm)
- UPPER DERMIS (Papillary) ───────────┼───────────────────────────┐
- │ STSG (Thick: 0.45–0.6 mm)│
- LOWER DERMIS (Reticular) ───────────┴───────────────────────────┤ FTSG
- │ (Full Dermis)
- SUBCUTANEOUS ADIPOSE ───────────────────────────────────────────┴───────────────
- [ Meticulously defatted down to glistening white dermis in FTSG ]
- Split-Thickness Skin Grafts (STSG)
Harvest & Anatomy: Harvested using an electric or pneumatic dermatome (e.g., Zimmer, Padgett) or a manual Weck blade. Contains the entire epidermis and a variable portion of the dermis: thin (0.15–0.30 mm), medium (0.30–0.45 mm), or thick (0.45–0.60 mm). Common donor sites: anterolateral thigh, buttocks, upper arm.
Donor Site Re-epithelialization: Because the deep reticular dermis remains intact, the donor site heals spontaneously within 10 to 14 days through keratinocyte proliferation and migration out of deep dermal appendages (eccrine sweat ducts and hair follicle outer root sheaths).
Biological Advantages: Exceptionally low metabolic and oxygen requirements. STSGs survive ('take') on compromised or marginally vascularized wound beds where FTSGs would fail.
Cosmetic & Functional Disadvantages: Severe secondary contracture (shrinking by 40% to 60%), resulting in a thin, depressed, shiny, hairless patch with significant hypopigmentation or hyperpigmentation and poor resistance to shear trauma.
Full-Thickness Skin Grafts (FTSG)
Harvest & Anatomy: Consists of the epidermis and the entire dermis , harvested surgically with a scalpel. The donor defect cannot re-epithelialize and must be closed primarily in a linear fashion.
The Obligate Defatting Process: After harvesting, the graft must be pinned or draped over the surgeon's finger and meticulously defatted using curved Iris or tenotomy scissors. Every trace of yellow subcutaneous adipose tissue must be trimmed away until the pristine, glistening white, fibrous dermis is exposed. Subcutaneous fat contains virtually no open capillary loops; if left on the graft, it acts as a physical barrier that blocks passive serum diffusion, causing 100% graft necrosis.
Contracture Dynamics (Primary vs. Secondary):
Primary Contracture: The immediate elastic recoil of the graft upon excision from the donor site, mediated by dermal elastin fibers. FTSGs exhibit pronounced primary contracture (shrinking 10%–20% immediately upon harvest).
Secondary Contracture: The cicatricial contraction occurring during wound healing, mediated by myofibroblasts in the recipient bed. FTSGs undergo minimal to zero secondary contracture because the dense, intact dermis mechanically suppresses recipient-bed myofibroblast activity.
Aesthetic Match: Provides superior color, texture, thickness, sebaceous pore blending, and sensation compared to STSGs.
Common FTSG Donor Sites
Preauricular and Retroauricular (Postauricular) Sulcus: Premier donor sites for facial defects (nasal tip, ala, cheek); superb color match and sun-damage blending.
Supraclavicular Fossa: Excellent color and texture match for lower face and neck defects.
Upper Eyelid: Ultra-thin skin; the gold standard for reconstructing contralateral full-thickness eyelid defects.
Inner Upper Arm / Clavicular Region: High tissue laxity; used for larger defects where the donor scar can be concealed.
The Three Phases of Graft Survival ('Take')
For a free skin graft to survive, it must progress through three strictly timed physiological stages: PHASE 1: PLASMATIC IMBIBITION (Hours 0 to 48)
Passive absorption of wound bed transudate like a sponge.
Graft weight increases 30–40%; pale, cyanotic, edematous.
Fibrin layer anchors graft to bed.
- │
- ▼
- PHASE 2: INOSCULATION (Days 2 to 4)
Direct microvascular end-to-end alignment ('kissing vessels').
Host capillary sprouts anastomose with graft dermal vessels.
True circulation restored; graft turns pink/erythematous.
- │
- ▼
- PHASE 3: REVASCULARISATION / NEOVASCULARISATION (Day 4 Onwards)
Active host endothelial capillary ingrowth & angiogenesis.
Lymphatic drainage established (Days 5–7), edema clears.
Fibrous anchoring & nerve regeneration (Weeks 4–8).
Plasmatic Imbibition (Hours 0 to 48):
During the first 48 hours, the graft is entirely avascular. It survives solely through passive diffusion of nutrients, electrolytes, glucose, and oxygen from the transudate/serum of the recipient wound bed capillaries.
The graft absorbs fluid like a sponge, increasing in weight by 30% to 40% , appearing swollen, pale, and mildly cyanotic. An extracellular fibrin glue anchors the graft to the host bed.
Inosculation (Days 2 to 4):
Capillary endothelial sprouts from the recipient bed physically contact and align with the pre-existing, cut microvascular lumens of the deep graft dermis.
Direct end-to-end vascular anastomoses form ( 'kissing vessels' ). True microcirculatory blood flow is established across the junction, and the graft turns pink and erythematous.
Revascularisation / Neovascularisation (Day 4 Onwards):
True angiogenesis takes place: new host vascular channels actively invade the graft dermis, while old graft endothelial conduits are remodeled or replaced.
Lymphatic drainage is re-established by day 5 to 7, resolving graft edema.
Fibroblast proliferation deposits mature collagen, permanently securing the graft to the bed.
Sensory reinnervation begins at 4 to 8 weeks, progressing centripetally from the borders, though protective sensation rarely reaches 100%.
Bolster (Tie-Over) Dressings
Mechanical shearing forces, seroma, or haematoma will tear delicate budding microvessels, terminating inosculation and causing graft necrosis. A bolster (tie-over) dressing is mandatory:
Long non-absorbable sutures (e.g., 4-0 silk or nylon) placed around the perimeter of the graft are tied securely over a non-adherent contact layer (petrolatum gauze) and a resilient cotton or foam bolus.
The bolster immobilizes the graft, eliminates dead space, exerts uniform downward pressure (20–30 mmHg) to expel exudate, and prevents shearing trauma. The bolster is left undisturbed for 5 to 7 days .
Summary Table: Split-Thickness vs. Full-Thickness Skin Grafts
Parameter Split-Thickness Skin Graft (STSG) Full-Thickness Skin Graft (FTSG)
Anatomical Layers Included Epidermis + variable portion of superficial dermis. Epidermis + entire dermis (defatted down to dermis).
Harvest Method Dermatome (electric, air-driven, or Weck blade). Surgical scalpel; manual defatting with scissors.
Donor Site Healing Re-epithelializes spontaneously from appendages (10–14 days). Must be closed primarily with linear layered sutures.
Metabolic Requirements Very low; survives on compromised beds. Moderate to high; requires rich vascular recipient bed.
Primary Contracture (Recoil) Minimal (slight initial shrinkage). Pronounced (10%–20% immediate elastic recoil).
Secondary Contracture (Healing) Severe (40%–60% surface area shrinkage). Minimal to none (thick dermis inhibits myofibroblasts).
Cosmetic & Texture Match Poor; shiny, atrophic, pigmentary mismatch, hairless. Superior; matches natural color, texture, and pores.
Primary Clinical Uses Extensive defects, burn reconstruction, compromised beds. Facial defects (nasal tip, ala, eyelids, lips, ears).
- Surgical Complications & Management
- 1. Postoperative Haematoma
Significance: Haematoma formation represents the single most common cause of both skin graft failure and cutaneous flap necrosis .
Pathophysiology: Accumulated blood forms a physical barrier that separates the flap or graft from the underlying bed, halting plasmatic imbibition and inosculation. Furthermore, free iron and breakdown products from decomposing red blood cells trigger severe, sustained arteriolar vasospasm and free-radical cytotoxicity.
Management:
An expanding hematoma is a surgical emergency. The patient must be returned immediately to the procedure room.
Sutures must be removed, the clot evacuated, the cavity copiously irrigated with sterile saline, and active bleeding vessels identified and electrocoagulated.
The flap or graft is repositioned, and a compressive pressure dressing is reapplied.
- 2. Flap Ischemia & Necrosis: Arterial vs. Venous Insufficiency CLINICAL EVALUATION OF FLAP ISCHEMIA
- │
- ┌───────────────┴───────────────┐
- ▼ ▼
- ARTERIAL INSUFFICIENCY VENOUS CONGESTION (More Common)
- Pale, cool, white/ashen skin - Violaceous, dusky purple, cyanotic skin
- Capillary refill: >4–5 sec - Capillary refill: <1 sec (brisk/pooling)
- Pinprick: No bleeding - Pinprick: Immediate dark, copious venous blood
- │ │
- ▼ ▼
Management: Management:
- Cut tension-bearing sutures - Cut distal sutures immediately
- Warm compresses - Medicinal leeches (Hirudo medicinalis)
- Hyperbaric oxygen (HBOT) - Mandatory Ciprofloxacin (anti-Aeromonas)
- Arterial Insufficiency
Presentation: The distal flap appears pale, white, or mottled ashen; skin temperature is cool; capillary refill time (CRT) is markedly prolonged ( >4–5 seconds ); and pinprick fails to produce bleeding.
Etiology: Excessive closure tension, severe pedicle kinking, or vasospasm.
Management: Release distal tension-bearing sutures immediately; apply warm sterile saline compresses; consider hyperbaric oxygen therapy (HBOT).
Venous Congestion
Presentation: Clinically more common and equally destructive as arterial insufficiency. The flap appears violaceous, mottled blue-purple, or dusky cyanotic; capillary refill is brisk and instantaneous ( <1 second ) due to venous blood pooling; and pinprick produces immediate, copious, dark plum-colored blood.
Etiology: Inadequate venous outflow leading to retrograde venous stasis, severe interstitial tissue edema, capillary thrombosis, and secondary arterial shutdown.
Management:
Promptly release distal sutures to decompress tissue.
Medicinal Leeching (Hirudo medicinalis): Leeches are applied to the congested flap (1–3 leeches every 4–8 hours). Leech saliva contains hirudin (a potent direct thrombin inhibitor), hyaluronidase, and vasodilators. Leeches actively decongest the flap by extracting 5–10 mL of blood during feeding, followed by prolonged passive venous oozing for up to 24 hours.
Mandatory Antibiotic Prophylaxis: Hirudo medicinalis carries Aeromonas hydrophila as an obligate bacterial endosymbiont within its gut. Leech therapy without antimicrobial coverage causes destructive soft tissue infection, abscesses, and graft necrosis. Prophylactic ciprofloxacin (500 mg twice daily orally) or trimethoprim-sulfamethoxazole is mandatory.
3. Surgical Site Infection (SSI)
Incidence: Clean cutaneous surgery carries an exceptionally low baseline infection rate ( <1% to 3% ).
Primary Pathogens: Staphylococcus aureus (>70% of cases), followed by beta-hemolytic Streptococcus , and Pseudomonas aeruginosa (particularly in surgical procedures involving the cartilage of the external ear or nose).
Antibiotic Prophylaxis Guidelines: Routine oral or parenteral antibiotic prophylaxis is not indicated for clean cutaneous surgery. European consensus guidelines restrict antibiotic prophylaxis strictly to high-risk clinical scenarios:
Procedures involving mucous membranes (oral cavity, lips) or the groin/perianal region.
Cartilaginous surgery of the external ear or nasal wedge excisions (risk of suppurative chondritis, which requires coverage against Pseudomonas and S. aureus ).
Lower extremity surgery in patients with severe chronic venous stasis, lymphedema, or peripheral arterial disease.
Patients with high-risk cardiac conditions: prosthetic heart valves, prior history of infective endocarditis, or prosthetic joint replacement performed within the preceding 3 to 6 months.
Regimen: A single oral dose of Amoxicillin/clavulanic acid (1 g to 2 g) or Cefazolin (2 g IV) administered 30 to 60 minutes prior to surgical incision (Clindamycin in penicillin-allergic patients).
4. Wound Dehiscence
Etiology: Premature suture removal, excessive mechanical wound tension, untreated hematoma, or surgical site infection.
Management: Dehisced wounds on the face can occasionally undergo urgent debridement and primary re-closure if evaluated within the first 12–24 hours without infection. Infected or heavily inflamed dehisced wounds should be allowed to heal by secondary intention utilizing hydrocolloid, alginate, or negative-pressure wound therapy.
- 5. Pathological Scarring: Hypertrophic Scars vs. Keloids
- Clinical Differentiation
Hypertrophic Scars: Raised, erythematous, pruritic scars that remain strictly confined within the boundaries of the original surgical incision . They typically develop within 4 to 8 weeks post-surgery and often undergo spontaneous gradual regression over 1 to 2 years.
Keloids: Raised, firm, claw-like, violaceous nodules or plaques that actively invade and extend beyond the original surgical margins into adjacent normal, uninjured skin . They do not regress spontaneously and frequently recur following simple surgical excision.
High-Risk Anatomical Sites: Presternal chest, deltoid region, upper back, and earlobes.
Histopathological Comparison
Hypertrophic Scars: Composed of organized, parallel bundles of collagen (predominantly type III collagen ) running parallel to the epidermal surface, with abundant myofibroblasts and microvessels.
Keloids: Characterized by haphazard, thick, highly hyalinized, glassy, eosinophilic collagen bands termed 'keloidal collagen' (predominantly type I collagen ) with a marked paucity of myofibroblasts and complete absence of skin appendages.
Evidence-Based Management Algorithm
First-Line Therapy: Intralesional Corticosteroids:
Triamcinolone acetonide (TAC) (10 to 40 mg/mL) injected directly into the dense fibrous core of the scar every 3 to 4 weeks. TAC inhibits fibroblast proliferation, downregulates TGF-beta1, and stimulates collagenase synthesis.
Combination Intralesional Therapy (TAC + 5-Fluorouracil):
Combining TAC (40 mg/mL) with 5-fluorouracil (5-FU, 50 mg/mL) in a 1:9 or 2:8 volume ratio yields superior flattening and symptom relief compared to TAC monotherapy while drastically reducing corticosteroid-induced complications (skin atrophy, depigmentation, telangiectasia).
Topical Silicone Gel Sheeting:
Worn for >=12 to 24 hours daily for at least 3 to 6 months. Increases stratum corneum hydration, normalizes trans-epidermal water loss (TEWL), and downregulates fibroblast hyperactivity.
Pulsed Dye Laser (PDL 595 nm):
Photocoagulates scar microvasculature, inducing hypoxia, downregulating TGF-beta, and stimulating collagen remodeling.
Surgical Excision + Adjuvant Radiotherapy:
Simple surgical excision of a keloid carries a disastrous recurrence rate ( 50% to 100% ). If re-excision is performed, it must be paired with immediate postoperative adjuvant therapy: intralesional corticosteroids or superficial fractionated radiotherapy (12 to 15 Gy in 3 fractions initiated within 24 to 48 hours post-excision).